Pfizer Inc
NYSE: PFE
▼
35.45
-0.10
-0.28%
1 Day
-
Open
35.66
-
Previous Close
35.55
-
Volume (Avg)
15.69M (17.44M)
-
Day's Range
35.35-35.66
-
52Wk Range
29.83-35.84
-
Market Cap.
210.83B
-
Dividend Rate (Yield)
1.28 (3.61%)
-
Beta
1.01
-
Shares Outstanding
5.95B
-
P/E Ratio (EPS)
25.91 (1.37)
Top Stories
-
Morgan Stanley Upgrades Pfizer (PFE) to Overweight
StreetInsider 21 mins agoMorgan Stanley upgraded Pfizer (NYSE: PFE) from Equalweight to ... This is a premium only article. To continue reading this article and more like it please sign-in or upgrade to StreetInsider.com Premium below (Free Trial)
-
Ad Com vote split on Pfizer's Sutent for certain kidney cancer patients
Seeking Alpha -
Pfizer announces outcome of FDA committee meeting for Sutent in patients at high risk of recurrent RCC after surgery
Pharmabiz -
Free Bonus! Online Stock! 35% discount bonus for Abilify pills! Pfizer patient assistance form...
ravenousmonster.com -
Incognito Online Store! Worldwide Shipping! Don't wait - order Genegra at Cheapest Prices! Doctor games surgery...
thewartburgwatch.com 4 hrs agoem was beginning up the complete pelvic exam video of my cheap, cleveland clinic solon appointment center but laboratoire picking of his pfizer. Cheap tried few to warn ccf appointment center. I seemed off, a cheap attacking gently after his ...
-
Pfizer Supports General Practice Physicians’ Medical Education In Nigeria, Ghana, Kenya
uncova.com -
Cheap Product Online! Need To Know! 35% discount bonus for Cymbalta pills online! Pfizer patient assistance tikosyn...
ravenousmonster.com -
City Planning Commission Approves Controversial Pfizer Site Rezoning
Gothamist -
Pfizer Inc. (PFE) Closes 0.28% Down on the Day for September 19
Equities -
Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery
Business Wire -
Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carc...
ih.advfn.com -
City Planning signs off on rezoning of Rabsky’s Pfizer sites
The Real Deal -
Rezoning of Williamsburg’s Pfizer site moves forward with City Planning approval
Curbed -
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
Business Wire -
Community News for the West Hartford Edition
Courant 18 hrs ago -
Precision Medicine Market Insight to 2022 Focuing on key players like Ferrer InCode, Intomics, Teva Pharmaceutical, Pfizer, LabCor & More
Medgadget -
Oncology Biosimilars Global Market Key Players – BIOCAD, Pfizer Inc, Biocon, Celltrion Inc, STADA Arzneimittel AG Analysis and Forecast to 2022
Medgadget -
Pfizer : Is Accelerating the Supply Chain
4 Traders
